By Jerrico Perez, Samantha Fow
Mar 20, 2025
The U.S. Virgin Islands Cannabis Advisory Board (CAB) has confirmed that cannabis cultivation and micro-cultivation license applications will be released on March 31, 2025.
By Vicente LLP
Mar 18, 2025
As Vicente LLP celebrates its 15th anniversary this year, we reflect on 15 milestones that highlight our growth, commitment to advocacy, and the important role our firm has played in cannabis law, psychedelics law, and drug policy reform.
By Brandon Kurtzman, Neil Willner
Mar 11, 2025
As New York’s cannabis market evolves, regulators are ramping up enforcement. Licensees must have a proactive compliance strategy for their business to avoid fines and penalties. In this insights post, we dive into the key areas of compliance risk under the newly established Trade Practices Bureau, including ownership violations, license stacking, and fraudulent practices. We also highlight proactive steps businesses can take to stay ahead of regulatory changes and protect their licenses.
By Genevieve Meehan, Jerrico Perez
Mar 7, 2025
Have you heard about Colorado SB25-076—Intoxicating Substances & Social Equity Businesses? While state legislators introduced the bill with good intentions to protect public health and safety, some of the provisions could significantly impact businesses and consumers in the Colorado cannabis and natural medicine spaces. A public hearing on the bill will be held on Tuesday, March 11, 2025.
By Charles Alovisetti, Bridgette Nikisher
Mar 5, 2025
The Treasury Department recently suspended enforcement of the Corporate Transparency Act’s Beneficial Ownership Information reporting requirements meaning that businesses failing to submit or update their BOI reports by the March 21 deadline will not face fines, penalties, or enforcement actions. In this Insights post, we discuss the latest developments surrounding CTA enforcement, the Treasury’s plans to limit its scope, anticipated regulatory changes from FinCEN, and ongoing legislative and legal challenges that could reshape compliance obligations.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.